TIL therapy manufacturing
10 Aug 2023In this infographic, Cytiva addresses challenges at each stage of the TIL (Tumor-infiltrating lymphocyte) therapy manufacturing workflow. It considers the challenges of each stage and provides solutions. The workflow presented covers tumor tissue resection and transfer, tissue disaggregation and feeder cells, selection and expansion (pre-REP), TIL activation and expansion (REP), harvest and formulation, cryopreservation and shipment, and therapy delivery.
Related Products
Request Quote for All Products
Sepax™ C-Pro Cell Processing System
CytivaThe Sepax C-Pro Cell Processing System, which is comprised of the instrument, Sepax C-Pro protocol software, and kits, allows you to combine multiple processing steps in a versatile manner. These steps include but are not limited to enrichment, magnetic bead incubation, spinoculation, concentration, washing, dilution, and splitting.